In 2010, French consumers were seen to be increasingly open to self-medication with medicated skin care products, in particular with products perceived to be more natural, opting to reduce visits to doctors to obtain a specific treatment for such minor ailments, although semi-ethical drugs and Rx medicines continued to be popular because they are reimbursed. This trend, reinforced by the growing availability of OTC products in self-service areas of chemists/pharmacies, attracted new operators,...

Euromonitor International's Medicated Skin Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.

Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Medicated Skin Care market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market's major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Medicated Skin Care in France
Euromonitor International
May 2011
List of Contents and Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Category Data
- Bayer Sante Familiale Sas in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 1 Bayer Santé Familiale SAS: Key Facts
Summary 2 Bayer Santé Familiale SAS: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 3 Bayer Santé Familiale: Competitive Position 2010
- Cooperation Pharmaceutique Francaise Sas (cooper) in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 4 Cooperation Pharmaceutique Francaise SAS (Cooper): Key Facts
Summary 5 Cooperation Pharmaceutique Francaise SAS (Cooper): Operational Indicators
- Company Background
- Production
Summary 6 Cooperation Pharmaceutique Francaise SAS (Cooper): Production Statistics 2010
- Competitive Positioning
Summary 7 Cooperation Pharmaceutique Francaise SAS (Cooper): Competitive Position 2010
- Juva Santé, Laboratoires in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 8 Laboratoires Juva Santé: Key Facts
Summary 9 Laboratoires Juva Santé: Operational Indicators
- Company Background
- Production
Summary 10 Laboratoires Juva Santé: Production Statistics 2010
- Competitive Positioning
Summary 11 Laboratoires Juva Santé: Competitive Position 2010
- Laboratoires Mcneil in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 12 Laboratoires McNeil: Key Facts
Summary 13 Laboratoires McNeil: Operational Indicators
- Company Background
- Production
- Competitive Positioning
Summary 14 Laboratoires McNeil: Competitive Position 2010
- Pierre Fabre Sa, Laboratoires in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 15 Laboratoires Pierre Fabre SA: Key Facts
Summary 16 Laboratoires Pierre Fabre SA: Operational Indicators
- Company Background
- Production
Summary 17 Laboratoires Pierre Fabre SA: Production Statistics 2010
- Competitive Positioning
Summary 18 Laboratoires Pierre Fabre SA: Competitive Position 2010
- Théraplix SA in Consumer Health (france)
- Strategic Direction
- Key Facts
Summary 19 Théraplix SA: Key Facts
- Company Background
- Competitive Positioning
Summary 20 Théraplix SA: Competitive Position 2010
- Executive Summary
- Consumer Health Sees Modest, But Faster, Growth in Comparison With 2009
- 2010 Is A Year Full of Important Events
- New OTC Proton Pump Inhibitors Behind Best Value Share Performances
- Chemists/pharmacies Continues To Be the Main Distribution Channel
- Low Overall Performances for the Forecast Period
- Key Trends and Developments
- Switches Driving Sales Growth
- Ageing Population A Key Driver for Consumer Health
- Further Increases in Tobacco Prices Responsible for New Growth of Nrt Smoking Cessation Aids
- Tightened Legislation Concerning Dietary Supplements Expected for 2011
- Further Competition Expected at Retailing Level
- Market Indicators
- Market Data
- OTC Registration and Classification
- Advertising
- Packaging and Labelling
- Distribution
- Vitamins and Dietary Supplements Registration and Classification
- EU Legislation
- Self-medication/self-care and Preventive Medicine
- Generics
- Switches
Summary 21 OTC Healthcare Switches 2008-2010
- Definitions
List of Tables
- Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010
- Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
- Table 3 Acne Treatments by Format: % Value Breakdown 2005-2010
- Table 4 Medicated Skin Care Company Shares by Value 2006-2010
- Table 5 Medicated Skin Care Brand Shares by Value 2007-2010
- Table 6 Acne Treatments Brand Shares by Value 2007-2010
- Table 7 Hair Loss Treatments Brand Shares by Value 2007-2010
- Table 8 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
- Table 9 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015
- Table 10 Consumer Expenditure on Health Goods and Medical Services 2005-2010
- Table 11 Life Expectancy at Birth 2005-2010
- Table 12 Sales of Consumer Health by Category: Value 2005-2010
- Table 13 Sales of Consumer Health by Category: % Value Growth 2005-2010
- Table 14 Sales of Consumer Health by Region: Value 2005-2010
- Table 15 Sales of Consumer Health by Region: % Value Growth 2005-2010
- Table 16 Consumer Health Company Shares by Value 2006-2010
- Table 17 Consumer Health Brand Shares by Value 2007-2010
- Table 18 Penetration of Private Label by Category 2005-2010
- Table 19 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
- Table 20 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
- Table 21 Forecast Sales of Consumer Health by Category: Value 2010-2015
- Table 22 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

Pharmaceutical Market Research

Medicated Skin Care in France

Medicated Skin Care in France

Why buy this report?

Contents

Related products